This inventor holds 1 USPTO granted patent. Top assignees: Keio University, Regimmune Corporation. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2021
Title: Shinsuke Inuki: Innovator in Natural Killer T Cell Activation
Introduction
Shinsuke Inuki is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of immunology, particularly in the activation of natural killer T cells. His innovative work has led to the development of a novel compound that has potential applications in pharmaceutical compositions.
Latest Patents
Inuki holds a patent for a compound or salt thereof that acts as a natural killer T cell activator. The patent addresses the need for a new compound capable of activating these cells, which play a crucial role in the immune response. The invention includes a natural killer T cell activating agent containing the compound and a pharmaceutical composition that incorporates it. The compound is represented by a specific formula, and it is designed to enhance the activation of natural killer T cells effectively.
Career Highlights
Throughout his career, Shinsuke Inuki has worked with esteemed institutions, including Keio University and Regimmune Corporation. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Inuki has collaborated with notable colleagues such as Junichiro Kishi and Toshihiko Aiba. These partnerships have further enriched his research and development efforts in the area of natural killer T cell activation.
Conclusion
Shinsuke Inuki's work in the field of immunology, particularly with his patent on natural killer T cell activators, showcases his innovative spirit and dedication to advancing medical science. His contributions have the potential to impact therapeutic approaches in immunology significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile